Vertex Pharmaceuticals Inc financials at a glance
Year | Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$6.21B | $4.16B | $3.05B | $2.49B | $1.70B | $1.03B | $580.42M | $1.21B | $1.53B | $1.41B | $143.37M | $101.89M | $175.50M | $199.01M | $216.36M | $160.89M | $102.72M | $7.57B | $8.93B | $9.87B | $0.00M |
GM % | Gross Margin % |
|
58.65% | 44.69% | 40.08% | 35.72% | 26.09% | -8.53% | -57.90% | 16.47% | 31.52% | 44.12% | -17.69% | -60.18% | 2.18% | -40.65% | -80.90% | 6.52% | 6.42% | 47.78% | 59.60% | 55.16% | 0.00% |
OM | Operating Margin |
|
46.24% | 28.87% | 21.79% | 15.78% | 0.66% | -45.01% | -110.52% | -12.92% | 3.18% | 15.72% | 0.00% | 0.00% | -261.18% | -207.36% | -104.17% | -88.10% | -133.60% | 36.69% | 49.03% | 43.65% | 0.00% |
EPS | Earnings Per Share |
|
$-1.65 | $-1.86 | $-3.03 | $-3.27 | $-3.64 | $-3.48 | $-0.50 | $1.18 | $-1.58 | $-2.17 | $-1.11 | $0.85 | $1.95 | $4.08 | $5.33 | $10.32 | $13.02 | $14.88 | $15.23 | $0.00 | |
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | -0.00% | -0.00% | 0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0.00% | 0.00% | 0.00% | 0 |
Sha. | Shares |
|
260.04m | 257.15m | 255.56m | 252.9m | 248.03m | 245.72m | 240.52m | 233.76m | 216.83m | 208.57m | 203.19m | 193.9m | 150.47m | 132.3m | 125.59m | 108.02m | 80.31m | 254.25m | 254.58m | 0m | 258.31m |
OCF | Operating Cash Flow |
|
$3.25B | $1.57B | $1.27B | $844.94M | $236.10M | $-365.43M | $-573.11M | $-60.67M | $267.84M | $143.74M | $-635.44M | $-427.59M | $-226.48M | $-252.48M | $-22.48M | $-172.05M | $-142.12M | $2.64B | $4.13B | $3.54B | $0.00M |
FCF | Free Cash Flow |
|
$2.99B | $1.49B | $1.17B | $745.52M | $179.54M | $-410.73M | $-564.40M | $-102.96M | $196.70M | $109.14M | $-673.50M | $-451.09M | $-258.66M | $-284.90M | $-54.90M | $-189.01M | $-154.66M | $2.41B | $3.93B | $3.53B | $0.00M |
FCFS | Free Cash Flow Per Share |
|
$11.52 | $5.82 | $4.62 | $2.35 | $0.73 | $-2.03 | $-2.65 | $-0.76 | $0.93 | $0.53 | $-3.36 | $-2.60 | $-1.84 | $-2.21 | $-0.48 | $-2.12 | $-1.97 | $9.35 | $15.33 | $12.72 | $0.00 |